The Center for Clinical and Translational Sciences (CCTS) is accepting applications for the CCTS Translational Technologies Core Laboratories Awards. The deadline to submit is March 1.
This funding is to support UTHealth faculty’s use of the CCTS Core Laboratories for clinical or translational research.
The awards are for up to $10,000 each in direct costs (no indirect costs are allowed). Funding will start approximately May 15, 2017 and the funds must be completely spent by Aug. 31, 2017 (no carry forward is possible). An additional full year of support is available for expenditure Sept. 1, 2017 through Aug. 31, 2018. Thus a full 16-month award may be requested for $20,000.
For the purposes of the Translational Technologies Core Laboratories Awards program, clinical and translational research is defined as one of the following:
- Patient-oriented research, (i.e., research conducted with human subjects or on material of human origin such as tissues, specimens and cognitive phenomena)
- Epidemiologic and behavioral studies on humans
- Outcomes research, health services research and other informatics-based research directly applicable to human health-related research
- Application of discoveries generated in the laboratory to clinical studies or application of clinical observations to laboratory studies, “bench to bedside and back”
- Enhancement of the adoption of best practices in the community, translation to the community
Studies that solely address issues of basic biomedical research and studies solely restricted to animal models of human disease will not be considered.
Studies that involve human or animal subjects must have IRB or animal protocol approval before funding can begin.
To apply, email requested information in one single-spaced Word document in Arial 11-point font to John.S.Riley@uth.tmc.edu by March 1. The following must be included:
- Title of project
- Name of Principal Investigator (PI) department, school/institution or co-PIs
- Names of co-investigators and their departments and schools/institutions
- NIH biographical sketch and NIH other support pages for the PI, co-PIs and any co-investigators
- Names of any trainees involved in the study such as students, residents, fellows, etc.
- IRB and/or animal protocol approval numbers or confirmation that it will be pending prior to funding
- A one-page structured abstract with the subheadings: Introduction, Hypothesis, Specific Aims, Methods, Analysis and Anticipated Results, describing the proposed study and how the Core Laboratory utilization will be important to the project
- A one-page budget. Funds may be used toward either full or partial defrayal of any CCTS Core Laboratory costs; no indirect funds are allowed
Priorities will be placed on projects involving team science and recently awarded CCTS T32 and K-awardees. For purposes of this funding through CCTS, only the following CCTS Core Laboratories are eligible for full or partial defrayal of Core Laboratory charges.
- DNA Sequencing and Genotyping Core Laboratory, Dianna M. Milewicz, Ph.D., director
- Quantitative Genomics & Microarray Core Lab, David Loose, Ph.D., director
- Clinical and Translational Proteomics Core Laboratory, Hongyu Wang, M.D., Ph.D., director
- Magnetic Resonance Imaging (MRI) Core, Ponnada A. Narayana, Ph.D., M.Sc., director
- Atomic Force Microscopy Laboratory, David Volk, Ph.D., director
- Preclinical CT Core, Delia Danila, Ph.D., director
- Genetics Core Laboratory, Dongchuan Guo, Ph.D., director
- Antibody Core Laboratory, Zhiqiang An, Ph.D., director
- Bioinformatics and High-Performance Computing Service Center, W. Jim Zheng, Ph.D., director
- Nanochemistry Service Center, David Volk, Ph.D., director
- Texas Therapeutics Institute, Zhiqiang An, Ph.D., director
Please contact Ponnada Narayana, Ph.D., director of Translational Technologies, CCTS, 713-500-7677 or firstname.lastname@example.org or contact the directors of the CCTS Core Laboratories for services that they can provide.